Naveen Gumpeni

A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and Biomarkers

Himisha Beltran, Clara Oromendia, Daniel C. Danila et al. · Clinical Cancer Research · 2018 · 275 citations · Full text

Medicine, Pharmacology, Urology +17

Functional outcomes following robotic prostatectomy using athermal, traction free risk-stratified grades of nerve sparing

Ashutosh Tewari, Adnan Ali, Sheela Metgud et al. · World Journal of Urology · 2013 · 46 citations

Medicine, Surgery, Urology +16

Repeatability and Reproducibility Assessment of the Apparent Diffusion Coefficient in the Prostate: A Trial of the <scp>ECOG‐ACRIN</scp> Research Group (<scp>ACRIN</scp> 6701)

Michael A. Boss, Bradley S. Snyder, Eun‐Hee Kim et al. · Journal of Magnetic Resonance Imaging · 2022 · 22 citations · Full text

Medicine, Radiology, Urology +13

Molecular alterations in prostate cancer and association with MRI features

David I. Lee, Jacqueline Fontugne, Naveen Gumpeni et al. · Prostate Cancer and Prostatic Diseases · 2017 · 20 citations

Medicine, Oncology, Urology +16

Inhibition of FGF receptor blocks adaptive resistance to RET inhibition in <i>CCDC6-RET</i> –rearranged thyroid cancer

Renuka Raman, Jacques A. Villefranc, Timothy M. Ullmann et al. · The Journal of Experimental Medicine · 2022 · 18 citations · Full text

Medicine, Genetics, Oncology +17